IL18 and acute kidney injury: Several studies have shown the efficacy of urinary biomarkers including interleukin-18 (IL-18); plasma neutrophil gelatinase-correlated lipocalin (NGAL); kidney injury molecule-1 (KIM-1) and liver-type fatty acid-binding protein (L-FABP) to detect AKI before change in serum creatinine.